HVA / DOPAC Ratio

Dopamine drives motivation, movement, and reward, and your body breaks it down through a chain of small chemical steps. This urine test compares two of those breakdown products. It is a research-grade window into peripheral dopamine metabolism, not a diagnostic test, and the specific HVA/DOPAC ratio has not been validated as a clinical marker. It is best used as one exploratory input alongside symptoms and other markers.

Dopamine processing connects to Parkinson's disease, mood disorders, gut-brain signaling, and how your body handles certain medications and dietary compounds. A shift in this ratio can hint that something in your peripheral nervous system, gut microbiome, kidneys, or diet is influencing dopamine turnover. Because urinary HVA and DOPAC come largely from outside the brain, however, the ratio should not be read as a direct window into brain chemistry.

What This Ratio Actually Measures

The ratio compares HVA (homovanillic acid) to DOPAC (3,4-dihydroxyphenylacetic acid). DOPAC is the more immediate breakdown product, made inside dopamine-producing nerve cells when dopamine is recycled or leaks from storage sacs. HVA sits further downstream, formed when DOPAC is processed by a second enzyme, often outside neurons in supporting brain cells and peripheral tissues. HVA can also be formed by a parallel route, in which dopamine is first converted to 3-methoxytyramine and then to HVA, meaning HVA is not derived solely from DOPAC.

Because DOPAC reflects what is happening close to the nerve cell itself and HVA reflects what happens after additional processing, the balance between them is sometimes used as a rough description of relative distal versus proximal dopamine metabolism. In human brain tissue, HVA is the more abundant metabolite. Whether urine reliably mirrors brain dopamine activity is not well established. Only about 12 percent of total body HVA comes from the brain, with a similar amount coming from the liver and large contributions from the kidneys. Urinary DOPAC is even more peripherally derived and is considered a less reliable signal of brain dopamine than HVA. Urinary levels are also shaped by dietary polyphenols and gut microbial activity.

Parkinson's Disease and Dopamine Turnover

Although Parkinson's disease is the condition most closely tied to dopamine biology, the clearest clinical use of urinary HVA is actually in pediatric neuroblastoma, not Parkinson's. In a small pilot study of people with Parkinson's, urinary HVA was elevated compared with controls, and the authors suggested HVA could serve as a non-invasive marker of how the body handles levodopa, the standard medication for the disease. Larger cerebrospinal fluid studies, however, have generally found that HVA and DOPAC are lower in early Parkinson's compared with controls, so the pilot finding should not be taken as settled.

Levodopa therapy itself produces large increases in both urinary HVA and DOPAC, and the two move together in proportion to the dose given. Studies of cerebrospinal fluid show that as Parkinson's progresses, the relationships between dopamine and its breakdown products shift, and people who develop levodopa-induced dyskinesias (involuntary movements) show different turnover patterns than those who do not. These findings come from spinal fluid, not urine, so the link to a urinary HVA/DOPAC ratio is indirect.

Depression and Mood Disorders

The evidence on dopamine breakdown in depression is conflicting. In one plasma study of 137 adults newly diagnosed with depression who had not yet started medication, composite measures combining DOPAC and HVA relative to dopamine were higher in people with major depressive disorder, suggesting increased dopamine turnover. The broader literature points the other direction: meta-analyses of cerebrospinal fluid studies, and several plasma studies, have found HVA to be lower in people with depression than in controls. No urine-based study has settled the question, so a urinary HVA/DOPAC ratio cannot be reliably interpreted as a marker of depression risk or severity in either direction.

Gut-Brain Connections

Your gut microbes can independently produce HVA and DOPAC from dietary polyphenols, such as hydroxytyrosol found in olives and olive oil. In a study of 60 adults with functional constipation, higher urinary HVA was tied to imbalanced gut microbiome patterns, suggesting that what is happening in your intestines may influence what shows up in this test. This is one reason a single urine sample, taken without attention to diet or microbiome status, can be hard to interpret.

Autism and Childhood Catecholamine Patterns

In a study of 156 children with infantile autism, urinary patterns of dopamine and its breakdown products including HVA and DOPAC were altered compared with neurotypical peers, with levels decreasing with age and shifting with medication. A second study of 50 autistic children confirmed altered catecholamine metabolism without finding a genetic explanation. These are research findings about altered metabolism, not validated diagnostic tools.

Cancer Detection: Where HVA Is Most Established

The clearest clinical use of urinary HVA is in pediatric neuroblastoma, a tumor that produces large amounts of dopamine and its metabolites. In 301 children with neuroblastoma, classical markers (HVA plus VMA) had a diagnostic sensitivity of about 84 to 86 percent, while a panel of 8 urinary catecholamine metabolites, which already includes HVA and VMA, improved sensitivity to about 95 percent. HVA and normetanephrine were the metabolites most commonly elevated in these tumors. This is the one setting where elevated urinary HVA has a well-defined clinical meaning.

Separately, in a prospective study of 1,618 adults, higher plasma HVA was linked to greater colon cancer risk (odds ratio 1.46 per log2 increase, and 1.72 comparing highest to lowest fifths). The biological reason is not fully clear, and the measurement was in blood rather than urine, so this does not directly translate to interpreting your urinary HVA/DOPAC ratio.

Why This Ratio Is Not a Standard Clinical Test

This is the most important thing to understand: published research focuses almost entirely on absolute urinary HVA or absolute DOPAC, or on different ratios such as HVA divided by dopamine itself. A specific urinary HVA/DOPAC ratio is not a standard clinical index, has no widely accepted reference range, and has not been validated against hard outcomes like Parkinson's incidence, mortality, or response to treatment. No laboratory currently offers a validated HVA/DOPAC ratio as a clinical product with established reference ranges.

That does not make the underlying measurements useless. It does mean you should treat any ratio you calculate as a research-grade signal that complements your other data, not as a number with a fixed cutoff that decides anything on its own.

Tracking Your Trend Over Time

Because no standardized clinical thresholds exist and the ratio itself is unvalidated, your own baseline matters more than any external number. A single reading tells you very little. A trend across two or three readings, taken under similar conditions, may tell you whether something is shifting in how your body processes dopamine, but the clinical meaning of any such shift is uncertain.

If you are testing as part of broader exploratory monitoring, consider a baseline and a repeat measurement after any major change to diet, medications, or supplements that touch dopamine pathways. There is no evidence to support a specific retesting cadence for this ratio, so any tracking schedule should be discussed with your clinician and treated as exploratory rather than routine.

When Results Can Be Misleading

• Diet within 24 to 72 hours: olives, olive oil, and other polyphenol-rich foods supply hydroxytyrosol, which your body and gut microbes convert directly into HVA and DOPAC. A weekend Mediterranean feast before testing can shift your result without anything changing in your nervous system.
• Gut microbiome state: your microbes generate HVA and DOPAC from polyphenols, so dysbiosis, recent antibiotics, or changes in fiber intake can shift the ratio independently of brain dopamine activity.
• Peripheral sources: the kidneys, liver, and gut all produce dopamine and its metabolites. Only a small fraction of urinary HVA originates from the brain, and urinary DOPAC reflects brain activity even less reliably.
• Dopamine-related medications: levodopa for Parkinson's, dopamine prodrugs, and drugs that block dopamine reuptake or breakdown can dramatically change both numbers in the ratio. These are real biological effects, but they reflect the medication, not an underlying disease state.
• Collection timing and urine concentration: urinary metabolite levels vary with how concentrated your urine is. A single random spot sample is more variable than a properly collected 24-hour sample.

What an Unexpected Result Should Make You Do

If your ratio looks meaningfully different from your baseline or from what you expected, do not act on a single reading. First, repeat the test under cleaner conditions: standardized timing, attention to recent diet, and clear notes on any new medications or supplements. Then put the result in context with other tests.

Pair this test with absolute urinary HVA and DOPAC values, and consider a broader organic acids panel that captures other neurotransmitter pathways. If you have neurological symptoms, an evaluation with a neurologist is appropriate. If your concern is mood or motivation, integrate this result with sleep, exercise, gut health, and mental health assessment rather than treating it as a stand-alone answer. Remember that this ratio is not a validated clinical marker, so it should not drive treatment decisions on its own.